TP53 and neoplasm: (2018) in a mouse model of SCLC based on the inactivation of Rb1, Trp53, and p130. Future work is needed to reveal whether the tumors they described share common denominators with tumors we observed here and to what extent the different driver lesions engineered into these models are responsible for the distinct tumor characteristics.